Sun Pharma Advanced Research Co Ltd (SPARC) Stock Price & News

SPARC:NSE

Sun Pharma Advanced Research Co Ltd

₹193.78

-1.21%

(-2.38) 1D

Nov 6, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Last report

Nov 2, 2026

Fiscal period

Q2 2027

- / -

Revenue / Est. (INR)

536.50M / -

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	84.50M	18.53B	399.20M	536.50M
Cost of goods sold	72.10M	115.06M	76.60M	99.50M
Cost of revenue	72.10M	115.06M	76.60M	99.50M
Research and development expenses	62.70M	28.44M	132.60M	92.50M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	424.60M	557.37M	448.00M	448.50M
Operating expense	604.50M	605.33M	684.60M	678.90M
Total operating expenses	676.60M	720.39M	761.20M	778.40M
Operating income	-592.10M	17.81B	-362.00M	-241.90M
Other non operating income	-	-116.03M	236.60M	-
EBT including unusual items	-803.50M	17.61B	-206.70M	-243.10M
EBT excluding unusual items	-679.90M	17.61B	-206.70M	-243.10M
Income tax expense	700.00K	-3.84M	1.10M	800.00K
Effective tax rate	-0.09%	-0.02%	-0.53%	-0.33%
Other operating expenses	91.50M	-3.44M	82.00M	115.90M
Net income	-804.20M	17.61B	-207.80M	-243.90M
Net profit margin	-951.72%	95.04%	-52.05%	-45.46%
Earnings per share	-	-	-	-
Interest and investment income	-	102.87M	-	-
Interest expense	-87.80M	-90.07M	-81.30M	-1.20M
Net interest expenses	-87.80M	12.80M	-81.30M	-1.20M
Depreciation and amortization charges	25.70M	22.96M	22.00M	22.00M
EBITDA	-570.75M	17.83B	-342.34M	-219.90M
Gain or loss from assets sale	-	-	-	-

Finance